CING
USDCingulate Inc. Common Stock
$3.700-0.070 (-1.857%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$3.770
High
$3.780
Low
$3.662
Volume
0.01M
Company Fundamentals
Market Cap
20.7M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.19M
Exchange
NCM
Currency
USD
52-Week Range
Low $3.02Current $3.700High $6.01
Related News
GlobeNewswire
Cingulate Presents Positive Phase 3 Results for CTx-1301 Demonstrating Statistically Significant Efficacy and Entire Active-Day Symptom Control
KANSAS CITY, Kan., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company developing and advancing a pipeline of next-generation pharmaceutical products utilizing its proprietary
View more
GlobeNewswire
Cingulate's Lead ADHD Candidate CTx-1301 Selected for Podium Presentation at AACAP Annual Meeting
KANSAS CITY, Kan., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company developing and advancing a pipeline of next-generation pharmaceutical products utilizing its proprietary
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.